These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11113376)

  • 1. Diagnosis of defects in the type 1 cytokine pathway.
    Lammas DA; Drysdale P; Ben-Smith A; Girdlestone J; Edgar D; Kumararatne DS
    Microbes Infect; 2000 Nov; 2(13):1567-78. PubMed ID: 11113376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human deficiencies in type 1 cytokine receptors reveal the essential role of type 1 cytokines in immunity to intracellular bacteria.
    Ottenhoff TH; de Boer T; Verhagen CE; Verreck FA; van Dissel JT
    Microbes Infect; 2000 Nov; 2(13):1559-66. PubMed ID: 11113375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infections with non-tuberculous mycobacteria and salmonellae in patients with genetic defects in the interleukin-12/interferon-gamma-mediated pathway of macrophage activation.
    van Dissel JT; Arend SM; Ottenhoff TH
    Neth J Med; 2001 Sep; 59(3):90-4. PubMed ID: 11583822
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of infections in the patient with Mendelian susceptibility to mycobacterial infection.
    Holland SM
    Microbes Infect; 2000 Nov; 2(13):1579-90. PubMed ID: 11113377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae.
    van de Vosse E; Hoeve MA; Ottenhoff TH
    Lancet Infect Dis; 2004 Dec; 4(12):739-49. PubMed ID: 15567123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of human host immunity to mycobacteria.
    Ottenhoff TH; Verreck FA; Hoeve MA; van de Vosse E
    Tuberculosis (Edinb); 2005; 85(1-2):53-64. PubMed ID: 15687028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria.
    Ottenhoff TH; Kumararatne D; Casanova JL
    Immunol Today; 1998 Nov; 19(11):491-4. PubMed ID: 9818540
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae.
    Ottenhoff TH; Verreck FA; Lichtenauer-Kaligis EG; Hoeve MA; Sanal O; van Dissel JT
    Nat Genet; 2002 Sep; 32(1):97-105. PubMed ID: 12205477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects in the interferon-gamma and interleukin-12 pathways.
    Rosenzweig SD; Holland SM
    Immunol Rev; 2005 Feb; 203():38-47. PubMed ID: 15661020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma and interleukin-12 pathway defects and human disease.
    Dorman SE; Holland SM
    Cytokine Growth Factor Rev; 2000 Dec; 11(4):321-33. PubMed ID: 10959079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway.
    Lammas DA; Casanova JL; Kumararatne DS
    Clin Exp Immunol; 2000 Sep; 121(3):417-25. PubMed ID: 10971505
    [No Abstract]   [Full Text] [Related]  

  • 12. [From gene to disease; mutations in interleukin-12-receptor-beta 1- and interferon-gamma-receptor-1 lead to nontuberculous mycobacterial infections and salmonellosis].
    van Dissel JT; Ottenhoff TH
    Ned Tijdschr Geneeskd; 2000 Sep; 144(38):1830-2. PubMed ID: 11020837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human host genetic factors in mycobacterial and Salmonella infection: lessons from single gene disorders in IL-12/IL-23-dependent signaling that affect innate and adaptive immunity.
    van de Vosse E; Ottenhoff TH
    Microbes Infect; 2006 Apr; 8(4):1167-73. PubMed ID: 16513390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men.
    Jouanguy E; Döffinger R; Dupuis S; Pallier A; Altare F; Casanova JL
    Curr Opin Immunol; 1999 Jun; 11(3):346-51. PubMed ID: 10375558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mendelian predisposition to mycobacterial infections in humans].
    Casanova JL
    J Soc Biol; 2000; 194(1):25-8. PubMed ID: 11107546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically determined susceptibility to mycobacterial infection.
    Patel SY; Doffinger R; Barcenas-Morales G; Kumararatne DS
    J Clin Pathol; 2008 Sep; 61(9):1006-12. PubMed ID: 18326015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mendelian susceptibility to mycobacterial disease: defects in the IL-12/IFNgamma pathway].
    Fieschi C
    Presse Med; 2006 May; 35(5 Pt 2):879-86. PubMed ID: 16710161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mendelian susceptibility to mycobacterial disease.
    Kumararatne DS
    Respiration; 2006; 73(3):280-2. PubMed ID: 16679750
    [No Abstract]   [Full Text] [Related]  

  • 19. Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells.
    Verhagen CE; de Boer T ; Smits HH; Verreck FA; Wierenga EA; Kurimoto M; Lammas DA; Kumararatne DS; Sanal O; Kroon FP; van Dissel JT ; Sinigaglia F; Ottenhoff TH
    J Exp Med; 2000 Aug; 192(4):517-28. PubMed ID: 10952721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans.
    MacLennan C; Fieschi C; Lammas DA; Picard C; Dorman SE; Sanal O; MacLennan JM; Holland SM; Ottenhoff TH; Casanova JL; Kumararatne DS
    J Infect Dis; 2004 Nov; 190(10):1755-7. PubMed ID: 15499529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.